EP Patent

EP0372862A3 — Cyclosporine binding protein and its use in an assay for biologically-active cyclosporine

Assigned to Childrens Research Institute · Expires 1990-12-27 · 35y expired

What this patent protects

A method of quantitatively estimating biologically-­ active cyclosporines, analogues, derivatives and metabolites by a competitive protein binding assay uses water-soluble binding proteins isolated from the cycloplasm of human and animal cells. Tracers include radioactive ato…

USPTO Abstract

A method of quantitatively estimating biologically-­ active cyclosporines, analogues, derivatives and metabolites by a competitive protein binding assay uses water-soluble binding proteins isolated from the cycloplasm of human and animal cells. Tracers include radioactive atoms, fluorescent molecules, enzymes, and chemiluminescent molecules. Solution and solid phase assay methods are disclosed. Also claimed are the water-soluble binding proteins.

Drugs covered by this patent

Patent Metadata

Patent number
EP0372862A3
Jurisdiction
EP
Classification
—
Expires
1990-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Childrens Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.